Clinical evaluation of sibutramine in obese type 2 diabetic patients refractory to dietary management.
MATERIAL AND METHODS: An open, non-comparative study was carried out to assess the efficacy and toleration profile of sibutramine, a new antiobesity drug, in promoting weight loss in obese type 2 diabetes mellitus subject who failed to reduce weight after.....